Daclatasvir,Sofosbuvir (Co-Administered) Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Daclatasvir 60 mg + Sofosbuvir 400 mg
Reference Brands: Daklinza + Sovaldi(Combo)
Category: Hepatitis
Daclatasvir and Sofosbuvir tablets are a potent oral antiviral combination for treating chronic Hepatitis C infection. This fixed-dose therapy targets multiple HCV genotypes by inhibiting viral replication enzymes. Manufactured under EU-GMP and USFDA standards, it is widely used in B2B supply, hospital tenders, and global markets with full regulatory support for quick registration. Daclatasvir,sofosbuvir (co-administered) is available in Tablet and strengths such as Daclatasvir 60 mg + Sofosbuvir 400 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Daclatasvir,sofosbuvir (co-administered) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Daclatasvir,sofosbuvir (co-administered) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Daclatasvir and Sofosbuvir Tablets are an oral, fixed-dose combination used to treat chronic Hepatitis C infection across multiple genotypes. Daclatasvir is an NS5A inhibitor, and Sofosbuvir is an NS5B polymerase inhibitor; together, they provide a highly effective, well-tolerated antiviral regimen. Available as 60 mg Daclatasvir and 400 mg Sofosbuvir tablets, manufactured under EU-GMP and USFDA standards. Ideal for B2B licensing, hospital tenders, and global distribution with full CTD dossiers for fast registration in regulated markets.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Daclatasvir + Sofosbuvir is used for the treatment of chronic hepatitis C virus (HCV) infection, mainly genotypes 1, 3, and others as per clinical requirement. It helps reduce viral load and supports complete viral clearance when taken as a combination therapy.
It is made from the active ingredients daclatasvir, an NS5A inhibitor, and sofosbuvir, an NS5B polymerase inhibitor. Together they block viral replication and prevent the hepatitis C virus from multiplying.
Common trade names include Daklinza (daclatasvir) and Sovaldi (sofosbuvir) when sold separately. Combined generic formulations are available in India and other regions under several brand names.
Daklinza (daclatasvir) is made by Bristol-Myers Squibb, and Sovaldi (sofosbuvir) is made by Gilead Sciences. Combination generics are produced by multiple licensed manufacturers in India and other countries.
The generic name is daclatasvir + sofosbuvir.
Brand names include Daklinza (daclatasvir), Sovaldi (sofosbuvir), and various combined generic brands depending on the region.
It is manufactured by Bristol-Myers Squibb and Gilead Sciences, along with licensed generic manufacturers in India and several other global regions.
Related Products
Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir
Strength:
Ombitasvir 12.5 mg / Paritaprevir 75 mg / Ritonavir 50 mg (tablet)+ Dasabuvir 250 mg (tablet)
Form: Tablet
Reference Brands: Viekira Pak® (US); Viekirax® + Exviera® (EU)
View Details
Glecaprevir/Pibrentasvir
Strength:
Glecaprevir 100 mg Pibrentasvir 40 mg
Form: Oral tablets
Reference Brands: Mavyret®
View Details
Ribavirin
Strength:
Tablet:200 mg, 400 mg, 600mg; Capsule:200 mg; Solution:40 mg/mL
Form: Tablets, Capsules and Oral Solution
Reference Brands: Rebetol®, Copegus®, Virazole®(EU & US)
View Details
Adefovir Dipivoxil
Strength:
10 mg
Form: Oral tablets
Reference Brands: Hepsera® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers
